Atlas

FDA-Inspected Site

Zhejiang Hisun Pharmaceutical Co., Ltd.

8 FDA inspections are on record for Zhejiang Hisun Pharmaceutical Co., Ltd. in Taizhou, China.

483· Form 483 issued

Taizhou, China · Last updated July 10, 2026

Overview

  • 8 FDA inspections are on record.
  • 6 inspections produced a Form 483.
  • The most recent recorded inspection date is 2024-06-21.

At a glance

Inspections

8

Form 483s

6

EIRs

1

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
17 Jun 2024 – 21 Jun 2024Human Drugs483On file
3 Jun 2019 – 7 Jun 2019Human Drugs483On file
7 Aug 2017 – 11 Aug 2017Human Drugs483On file
16 Jan 2017 – 19 Jan 2017Human Drugs483On file
2 Mar 2015 – 7 Mar 2015Human Drugs483On file
19 Jul 2012Not recordedClean
15 Sep 2011Not recorded483On file
9 Sep 2010Not recordedClean

Investigators

FDA investigators tied to this site in the record.

Peter E Baker3 insp.
Rajiv R Srivastava1 insp.
Taichun Qin1 insp.
Parul M Patel1 insp.
Lindsey M Schwierjohann1 insp.
Gang Wang1 insp.
Jose R Hernandez1 insp.
Azza Talaat1 insp.
Walden H Lee1 insp.
Uduak M Inokon1 insp.

Full site report

Get the verbatim findings behind Zhejiang Hisun Pharmaceutical Co., Ltd.'s 6 Form 483s

The full inspection record, as Atlas holds it, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat